Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship between tocilizu...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2013
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/95ca42b5c6ca459fb627e05c4c2b9400 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|